Table 2 Baseline characteristics of the survivors and non-survivors groups
Categories | Overall N = 1257 | Survivor N = 988 | Non-survivor N = 269 | P-value |
|---|---|---|---|---|
Demographic | Â | Â | Â | Â |
 Age | 62.49 ± 17.27 | 61.82 ± 17.52 | 64.94 ± 16.13 | 0.009 |
 Gender(male) | 715 (56.88%) | 558 (56.48%) | 157 (58.36%) | 0.58 |
 BMI | 29.57 ± 6.54 | 29.50 ± 6.32 | 29.81 ± 7.30 | 0.49 |
 SOFA | 7.44 ± 4.26 | 6.75 ± 3.76 | 9.98 ± 4.98 | < 0.001 |
Laboratory tests | Â | Â | Â | Â |
 Hemoglobin (g/dL) | 10.69 ± 2.44 | 10.80 ± 2.37 | 10.29 ± 2.64 | 0.002 |
 Platelets (K/uL) | 182.63 ± 102.33 | 188.74 ± 102.64 | 160.20 ± 98.15 | < 0.001 |
 WBC (K/uL) | 15.57 ± 12.23 | 14.86 ± 10.07 | 18.17 ± 17.84 | < 0.001 |
 MCV (fL) | 90.43 ± 7.11 | 90.12 ± 6.92 | 91.60 ± 7.68 | 0.002 |
 RDW (%) | 15.28 ± 2.59 | 15.09 ± 2.42 | 15.98 ± 3.04 | < 0.001 |
 TC (mg/dL) | 144.36 ± 44.34 | 146.53 ± 44.33 | 136.38 ± 43.53 | < 0.001 |
 HDL (mg/dL) | 41.06 ± 15.59 | 41.83 ± 15.83 | 38.25 ± 14.34 | < 0.001 |
 LDL (mg/dL) | 77.83 ± 33.98 | 78.91 ± 34.43 | 73.89 ± 32.02 | 0.032 |
 Albumin (g/dL) | 3.37 ± 0.62 | 3.41 ± 0.59 | 3.21 ± 0.70 | < 0.001 |
 Aniongap (mEq/L) | 17.98 ± 5.35 | 17.25 ± 4.55 | 20.68 ± 6.98 | < 0.001 |
 Bicarbonate (mEq/L) | 23.88 ± 4.49 | 24.33 ± 4.40 | 22.19 ± 4.44 | < 0.001 |
 BUN (mg/dL) | 30.19 ± 23.39 | 28.25 ± 21.91 | 37.35 ± 27.02 | < 0.001 |
 Calcium (mg/dL) | 8.65 ± 0.88 | 8.66 ± 0.81 | 8.63 ± 1.11 | 0.66 |
 Chloride (mEq/L) | 106.39 ± 6.48 | 106.34 ± 6.18 | 106.60 ± 7.51 | 0.556 |
 Creatinine (mg/dL) | 1.68 ± 1.59 | 1.58 ± 1.60 | 2.07 ± 1.50 | < 0.001 |
 Sodium (mEq/L) | 140.93 ± 5.30 | 140.85 ± 4.94 | 141.20 ± 6.43 | 0.331 |
 Potassium (mEq/L) | 4.60 ± 0.86 | 4.55 ± 0.83 | 4.80 ± 0.93 | < 0.001 |
 Alk. Phosphatase (U/L) | 100.47 ± 125.44 | 95.33 ± 102.14 | 119.33 ± 186.74 | 0.005 |
 INR | 1.62 ± 1.15 | 1.51 ± 0.93 | 2.03 ± 1.66 | < 0.001 |
 PT | 17.78 ± 12.81 | 16.45 ± 9.88 | 22.65 ± 19.47 | < 0.001 |
 PTT | 46.32 ± 32.33 | 44.54 ± 30.88 | 52.84 ± 36.51 | < 0.001 |
 ALT (U/L) | 300.35 ± 1225.85 | 266.36 ± 1175.83 | 425.18 ± 1389.52 | 0.06 |
 ALP (U/L) | 114.62 ± 138.79 | 106.99 ± 112.24 | 142.65 ± 207.06 | < 0.001 |
 AST (U/L) | 515.72 ± 1811.76 | 435.29 ± 1671.11 | 811.16 ± 2233.23 | 0.003 |
 Total Bilirubin (mg/dL) | 2.27 ± 5.11 | 1.78 ± 3.78 | 4.07 ± 8.11 | < 0.001 |
 TyG index | 9.21 ± 0.66 | 9.18 ± 0.64 | 9.33 ± 0.71 | < 0.001 |
 CRP (mg/dL) | 68.65 ± 73.62 | 69.90 ± 73.38 | 63.89 ± 76.24 | 0.747 |
 NLR | 13.22 ± 13.52 | 12.14 ± 11.52 | 16.90 ± 18.31 | < 0.001 |
Comorbidities | Â | Â | Â | Â |
 Hypertension | 534 (42.48%) | 425 (43.02%) | 109 (40.52%) | 0.463 |
 Myocardial Infarction | 274 (21.80%) | 216 (21.86%) | 58 (21.56%) | 0.916 |
 CHF | 356 (28.32%) | 275 (27.83%) | 81 (30.11%) | 0.462 |
 COPD | 176 (14.00%) | 135 (13.66%) | 41 (15.24%) | 0.509 |
 CAD | 295 (23.47%) | 234 (23.68%) | 61 (22.68%) | 0.73 |
 Atrial Fibrillation | 388 (30.87%) | 286 (28.95%) | 102 (37.92%) | 0.005 |
 Chronic Liver Disease | 141 (11.22%) | 102 (10.32%) | 39 (14.50%) | 0.054 |
 Stroke | 262 (20.84%) | 201 (20.34%) | 61 (22.68%) | 0.404 |
 Malignancy | 205 (16.31%) | 158 (15.99%) | 47 (17.47%) | 0.56 |
 Low HDL | 667 (53.06%) | 500 (50.61%) | 167 (62.08%) | < 0.001 |
 AKI_48 h | 874 (69.53%) | 650 (65.79%) | 224 (83.27%) | < 0.001 |